Celldex Therapeutics Inc. (CLDX)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

53 FRONTAGE ROAD HAMPTON, NJ 08827

Celldex Therapeutics Inc. develops a portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines, a novel, proprietary vaccine candidate for cholesterol management and a treatment to reduce complement-mediated tissue damage associated with cardiac by-pass surgery.

Data based on most recent fiscal year report
Market Cap282.859 Million Shares Outstanding135.99 Million Avg Volume2.494 Million
1-Yr BETA vs S&P TR Current Ratio5.22 Quick Ratio5.22
View SEC Filings from CLDX instead.
Q1 2019 All Institutions Hedge Funds 1
To trade CLDX now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 48 5 (0.51%)
Aggregate 13F shares on 03/31/2019: 2.866 Million 723.814 Thousand
Aggregate 13F shares on 12/31/2018: 3.425 Million 788.186 Thousand
Percent change: -16.34% -8.17%
Funds creating new positions: 9 1
Funds Adding to an existing position: 19 3
Funds closing out their position: 41 8
Funds reducing their position: 19 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CONRAD HERBERT J

  • Director
4,079,922 2019-05-16 1

MCMAHON GERALD PHD PRESIDENT AND CEO

  • Officer
  • Director
3,000 2019-05-14 8

SHANNON TIMOTHY M

  • Director
2,254,442 2019-05-13 0

VAN DEN BROEK RICHARD

  • Director
0 2019-05-09 0

BROWNLIE KEITH L

  • Director
20,000 2019-02-13 1

DAVIS THOMAS ANDREW CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-07 0

CATLIN AVERY W

  • Director
20,000 2018-12-24 0

MARINO JAMES J

  • Director
65,997 2018-08-24 2

KELER TIBOR EXECUTIVE VP & CSO

  • Officer
35,368 2018-06-15 2

PEPIN RONALD SR. VP & CBO

  • Officer
0 2018-06-13 1

MARUCCI ANTHONY S PRESIDENT & CEO

  • Officer
  • Director
0 2018-06-13 1

SHOOS KAREN L.

  • Director
0 2018-06-13 1

ELLBERGER LARRY

  • Director
0 2018-06-13 1

PENNER HARRY JR

  • Director
0 2018-06-13 1

WRIGHT RICHARD M. SR. VP & CCO

  • Officer
0 2018-06-13 1

CROWLEY ELIZABETH SR. VP &CPDO

  • Officer
0 2018-06-13 1

CAVANAUGH SARAH SVP OF CORP AFFAIRS & ADMIN.

  • Officer
0 2018-06-13 1

MARTIN SAMUEL BATES SVP AND CFO

  • Officer
0 2018-06-13 1

HEATH-CHIOZZI MARGO SVP OF REGULATORY AFFAIRS

  • Officer
0 2018-06-13 1

LAVALLEE THERESA SVP, REG.& PRECISION MEDICINE

  • Officer
0 2016-12-14 0

ELSTON GEORGE CHIEF FINANCIAL OFFICER

  • Officer
1,000 2016-08-31 0

MEDAREX INC

  • 10% Owner
No longer subject to file 2014-09-30 0

PAREKH RAJESH R

  • Director
2,000 2010-09-22 0

SCHALLER CHARLES R

  • Director
5,000 2010-09-09 0

NEWBOLD RONALD C SR. VP, BUSINESS DEV.

  • Officer
5,868 2009-01-06 0

PALUCK THOMAS S

  • FORMER 10% OWNER
No longer subject to file 2008-03-07 0

KEILANI TAHA

  • VP MEDICAL & REG AFFAIRS
2,000 2008-01-02 0

FREEMAN PAULA R

  • SR.DIR.HUMAN RESOURCES
2,955 2008-01-02 0

LORANTIS HOLDINGS LTD

  • 10% Owner
0 2007-04-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments